Pāriet uz saturu
HPB-ALL
Audums
Peripheral blood
Slimība
Precursor T-cell acute lymphoblastic leukemia
Metastāžu vieta
Peripheral blood (systemic T-ALL)
Sinonīmi
HPB/ALL, HPBALL, FCCH1018

Dokumenti

HPB-ALL

Cell line · Preces numurs 302895

HPB-ALL ir cilvēka prekursoru T-šūnu akūtas limfoblastiskās leikēmijas (T-ALL) šūnu līnija, kas izveidota no 14 gadus veca japāņu zēna perifērās asins...

€430.00bez nodokļa un piegādes izmaksām

Pielāgošana / Ieteikumi

Noliktavā
Lot
Ieteicams (jaunākā partija)
  • CoA
1

01Vispārīga informācija

Apraksts

HPB-ALL is a human precursor T-cell acute lymphoblastic leukemia (T-ALL) cell line established from the peripheral blood of a 14-year-old Japanese male patient. The line grows in suspension with lymphocyte-like morphology. HPB-ALL harbors a complex TP53 mutational profile with eight mutations across heterozygous and homozygous states, reflecting the genetic complexity of T-ALL at diagnosis. The line expresses T cell surface markers consistent with T-ALL biology, making it relevant for studies of T lymphoblast leukemia pathogenesis and drug responses.

HPB-ALL is applicable in studies of T-ALL biology, TP53 multi-mutant phenotype, anti-leukemic drug sensitivity (glucocorticoids, vincristine, asparaginase, nelarabine), Notch and JAK-STAT pathway analysis, and comparative studies within the T-ALL cell line panel. It is suitable for in vitro pharmacological assays and xenograft models in immunocompromised hosts for preclinical T-ALL drug evaluation. Doubling time approximately 50 hours.

Audums
Peripheral blood
Slimība
Precursor T-cell acute lymphoblastic leukemia
Metastāžu vieta
Peripheral blood (systemic T-ALL)
Pieteikumi
T-ALL biology; TP53 multi-mutant phenotype; anti-leukemic drug sensitivity (glucocorticoids, vincristine, asparaginase, nelarabine); Notch/JAK-STAT pathways; xenograft models; T-ALL panel comparative studies
Sinonīmi
  • HPB/ALL
  • HPBALL
  • FCCH1018

02Klasifikācija

Organisms
Cilvēks
Sekss
Vīrietis
Augšanas īpašības
Atsperes
Bioloģiskās drošības līmenis
1

03Raksturlielumi

Morfoloģija
Lymphoblast-like
Šūnu tips
T-cell
Laiks, kas nepieciešams, lai skaits dubultojās
~50 hours

04Identifikatori

Atsauce
HPB-ALL (Cytion catalog number 302895)
NCBI nodokļu identifikācijas numurs
9606
Cellosaurus
CVCL_1820

05Pazīmes un uzņēmība

Mutāciju profils
Mutation: p.Arg465His, Unspecified; Mutation: p.Ala134Ser, Unspecified; Mutation: p.Leu1574Pro, Heterozygous; Mutation: p.Asp2442fs*39, Heterozygous; Mutation: p.Arg159Ser, Unspecified; Mutation: p.Cys124Ter, Homozygous; Mutation: p.Arg273Cys, Unspecified; Mutation: p.Ser121Ter, Unspecified

06Apstrāde un audzēšana

Barotne
RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Papildinājumi
Supplement the medium with 10% FBS
Disociācijas reaģents
dilution
Pārstādīšana
Dilute the culture to 2–5 × 10⁵ cells/ml with fresh pre-warmed complete medium twice per week. No enzymatic dissociation required.
Sadalījuma attiecība
1 : 10 split
Sēšanas blīvums
3-5*10^5/ml
Šķidruma atjaunošana
Subculture : 2 times/week
Atkausēšana un kultivēšana
  1. Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.

  2. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.

  3. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.

  4. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.

  5. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.

  6. Centrifuge the mixture at 200 x g for 5 minutes, carefully discard the supernatant containing freezing medium.

  7. Follow the procedure described under Post-Thaw Recovery

07Kvalitātes kontrole un kriokonservācija

Saldēšanas barotne
As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability.
Uzglabāšanas nosacījumi

For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.

Piegādes nosacījumi

Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.

08Ziedotājs

Donora vecums
14 years
Etniskā piederība
Japanese

10Informācija par produktu

Sastāva tabula